Ciaramella Giuseppe — SEC insider filings
SEC reporting owner CIK 1786322. 34 insider filings on record with FilingPulse; latest filed 2026-09-25.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2020-10-02 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 15 filings — 582,225 shares, $28,636,956 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 72.
- Largest priced transaction: sale of 155,324 shares @ $32.06 ($4,979,687) in Beam Therapeutics Inc., filed 2023-07-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | President | 34 | — | 43 legs · 582,225 sh · $28,636,956 | 72 |
Insider filings — Ciaramella Giuseppe
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-25 | 4 | Beam Therapeutics Inc. (BEAM) | Gift (G): 123,407 @ $0 | EDGAR |
| 2026-06-22 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 6,505 @ $0.67 · Option exercise (M): 29,000 @ $1.03 · Option exercise (M): 6,505 (derivative) @ $0 · Option exercise (M): 29,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 11,810 @ $24.58 | EDGAR |
| 2026-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-02-26 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 35,000 @ $17 · Sale (S): 35,000 @ $32.00 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 7,434 @ $18.35 | EDGAR |
| 2025-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2025-02-03 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 53,500 @ $0.67 · Option exercise (M): 53,500 (derivative) @ $0 | EDGAR |
| 2024-11-08 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 51,110 @ $26.36 | EDGAR |
| 2024-10-16 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 27,318 @ $0.67 · Option exercise (M): 12,979 @ $4.22 · Option exercise (M): 1,457 @ $7.22 · Sale (S): 51,110 @ $26.27 · Option exercise (M): 27,318 (derivative) @ $0 · Option exercise (M): 12,979 (derivative) @ $0 · +1 more | EDGAR |
| 2024-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 4,534 @ $32.12 · Grant/award (A): 27,318 (derivative) @ $0 · Grant/award (A): 12,979 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2024-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 70,000 (derivative) @ $24.40 | EDGAR |
| 2023-10-24 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 90,900 @ $0.67 · Option exercise (M): 90,900 (derivative) @ $0 | EDGAR |
| 2023-07-25 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 69,438 @ $7.22 · Option exercise (M): 21,846 @ $7.22 · Sale (S): 155,324 @ $32.06 · Option exercise (M): 1,206 @ $7.22 · Sale (S): 1,206 @ $32.01 · Option exercise (M): 69,438 (derivative) @ $0 · +2 more | EDGAR |
| 2023-04-05 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 1,918 @ $30.31 · Sale (S): 1,754 @ $29.09 | EDGAR |
| 2023-03-31 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 20,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 9,106 @ $0.67 · Option exercise (M): 4,326 @ $4.22 · Option exercise (M): 40,297 @ $0.67 · Sale (S): 37,525 @ $37.14 · Sale (S): 13,704 @ $37.99 · Sale (S): 1,900 @ $39.07 · +4 more | EDGAR |
| 2023-01-03 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 4,500 @ $0.67 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4/A | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 18,211 (derivative) @ $0 | EDGAR |
| 2022-12-14 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 18,211 @ $0.67 · Option exercise (M): 8,652 @ $4.22 · Sale (S): 31,699 @ $42.30 · Sale (S): 13,933 @ $43.15 · Sale (S): 5,383 @ $43.87 · Option exercise (M): 18,211 (derivative) @ $0 · +1 more | EDGAR |
| 2022-04-04 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 15,000 @ $0 · Sale (S): 1,859 @ $59.11 | EDGAR |
| 2022-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-12-30 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 39,700 @ $0.67 · Option exercise (M): 39,700 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 2,607 @ $7.22 · Sale (S): 1,216 @ $85.39 · Sale (S): 1,101 @ $86.62 · Sale (S): 290 @ $87.34 · Option exercise (M): 2,607 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 4,289 @ $7.22 · Sale (S): 4,289 @ $85.20 · Option exercise (M): 25,104 @ $7.22 · Sale (S): 16,456 @ $85.38 · Sale (S): 8,648 @ $86.29 · Option exercise (M): 4,289 (derivative) @ $0 · +1 more | EDGAR |
| 2021-09-21 | 4/A | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 27,317 (derivative) @ $0 · Grant/award (A): 12,978 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 18,012 @ $0.67 · Option exercise (M): 18,012 (derivative) @ $0 | EDGAR |
| 2021-06-30 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 78,580 @ $17 · Sale (S): 2,405 @ $103.83 · Sale (S): 5,464 @ $104.40 · Sale (S): 7,040 @ $105.52 · Sale (S): 10,444 @ $106.35 · Sale (S): 10,829 @ $107.30 · +4 more | EDGAR |
| 2021-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 4,030 @ $0.67 · Grant/award (A): 25,000 @ $0 · Option exercise (M): 4,030 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-01-04 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 43,842 @ $1.03 · Sale (S): 2,299 @ $79.03 · Sale (S): 3,510 @ $80.12 · Sale (S): 8,809 @ $80.97 · Sale (S): 5,297 @ $82 · Sale (S): 2,805 @ $83.12 · +9 more | EDGAR |
| 2020-10-02 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 3,731 @ $0.67 · Option exercise (M): 3,731 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786322 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs